Epinephrine: Clinical Trials

10 trials of Epinephrine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 terminated. 10 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Terminated 10
Phase 12Terminated 2
Phase 31Terminated 1

Follow Epinephrine: new trials by email Literature Review of Epinephrine trials Research Report on Epinephrine

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial
Epinephrine 0.5 mcg/kg, Epinephrine 1 mcg/kg - Hypotension
Phase 2TerminatedBoston Children's Hospital152023-02-082026-07-07
Study Assessing Pain Relief After Replacement of the Knee
ATX-101, bupivacaine hydrochloride without epinephrine - Acute Postoperative Pain
Phase 2TerminatedAllay Therapeutics, Inc.1122022-06-072025-08-14
"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"
Exparel Injectable Product, Multi-Drug Cocktail (Ropivicaine, Epinephrine, Ketolorac, Clonidine) - Musculoskeletal Diseases, Soft Tissue Mass
Phase 2TerminatedAtlantic Health System1162021-01-272025-04-09
Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section
Bupivacaine, Morphine, Fentanyl - Pain, Referred
Phase 2TerminatedMontefiore Medical Center262018-07-192020-01-13
Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.
0.9% saline solution, oral betamethasone placebo, adrenaline - Children, Bronchiolitis
Phase 2 / Phase 3TerminatedAssistance Publique - Hôpitaux de Paris1952015-10-012017-09-12
Femoral Nerve Block for Femur Fracture Repair in Pediatrics
Ropivicaine, Epinephrine - Traumatic Femur Fracture
Phase 2TerminatedNationwide Children's Hospital192013-05-012018-01-25
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation, Arm C-Epinephrine Inhalation Aerosol CFC - Asthma
Phase 1 / Phase 2TerminatedAmphastar Pharmaceuticals, Inc.212012-11-012016-03-17
Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
E004 (epinephrine inhalation aerosol), 90 mcg/actuation, E004 Placebo, E004 (epinephrine inhalation aerosol), 125 mcg - Asthma
Phase 1 / Phase 2TerminatedAmphastar Pharmaceuticals, Inc.92009-12-012018-05-16
Mechanisms of Hypoglycemia Associated Autonomic Failure
naloxone, fructose, exercise - Diabetes Mellitus, Hypoglycemia
Phase 2TerminatedAlbert Einstein College of Medicine392008-03-012026-05-19
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Epinephrine, Metoprolol - Cardiac Arrest, Sudden Cardiac Death
Phase 2TerminatedDavid Haines, MD72007-01-012017-05-25

Conditions studied

Asthma (2)  ·  Bronchiolitis (1)  ·  Death, Sudden, Cardiac (1)  ·  Diabetes Mellitus (1)  ·  Dyspnea (1)  ·  Heart Arrest (1)  ·  Hypoglycemia (1)  ·  Hypotension (1)  ·  Musculoskeletal Diseases (1)  ·  Pain, Postoperative (1)  ·  Pain, Referred (1)  ·  Pure Autonomic Failure (1)  ·  Respiratory Sounds (1)  ·  Status Asthmaticus (1)  ·  Tachycardia, Ventricular (1)

Sponsors

Amphastar Pharmaceuticals, Inc. (2)  ·  Albert Einstein College of Medicine (1)  ·  Allay Therapeutics, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Atlantic Health System (1)  ·  Boston Children's Hospital (1)  ·  David Haines, MD (1)  ·  Montefiore Medical Center (1)  ·  Nationwide Children's Hospital (1)

Countries

United States (8)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Catherine E Ross, MD (1)  ·  David E Haines, MD (1)  ·  Jeffrey Bernstein, MD (1)  ·  Jim Shi, M.D., Ph.D. (1)  ·  Meredith Hawkins, M.D., M.S. (1)  ·  Nicole Elsey, MD (1)  ·  Vladimir Evilevitch, M.D. (1)

Results publications

PMID 22285545, PMID 22522612, PMID 26447426, PMID 26447431, PMID 2674208, PMID 28860128, PMID 32150492

NIH funding

2015 (1), K23HL148312 (1), R01DK079974 (1)